date:Nov 29, 2012
ur authority, F.D.A. will consider taking appropriate action with respect to the labeling of these products, such as requiring disclosure of the amount of caffeine in food products, limitations on intended use, or warnings about possible adverse effects.
The F.D.A. said it may engage expertise outside the agency, most likely through consultation with the Institute of Medicine and possibly through an advisory committee or other public meeting.
The F.D.A. said it will investigate toxic effects w